Dr. C Mohan @UTSWNews #ACR20 @rheumnow reviews IFN in SLE: 👉Diff't IFN assc w/diff't lupus manifestions 👉⬆️stim endosomal DNA/RNA sensors RLR7,8,9 may drive SLE 👉TLR7 & 9 in B cells impt for germinal ctrs & Ab prod’n 👉TLR7 is X-linked 👉IFNsig not track w/dz activity https://t.co/3KK3UvH8Ka

The synovio-entheseal complex theory is proposed in the pathogenesis of psoriatic arthritis. The ultrasound study showed a link in the severity of the sonographic findings in the joints and the entheses supporting this model @rheumnow #ACR20 Abstr#311

Sustained remission is rare, should we settle for sustained low disease activity? Abst#0480 ESPOIR Cohort says no, get remission if possible for better radiographic (Sharp) and fxnal (HAQ) scores. Maybe perfect isn't enemy of good? @RheumNow. #ACR20 https://t.co/QNQn9n27rm

Dr Alba reports that in GCA angiotensin II system appears to be activated. Losartan reversed changes and reduced inflammatory markers. Possible role in GCA treatment? @rheumnow #ACR20 Abstr#510 https://t.co/IPp3lD1BUH

Early RA pts may develop chronic widespread pain. Not all have fibromyalgia. Multiple areas of pain & inflammation ^ chronic pain & other factors ie women high initial pain longer symptoms @CRASCRRheum @RheumNow #ACR20 abstr#187 1/3 at onset have regional pain 1/4 at 1yr https://t.co/7qOxH4h7Dd https://t.co/IFO1uwyR0o

• https://twitter.com/drpnash/status/1324580305567584258

Dr Ferrada and colleagues assess relapsing polychondritis cohort for VEXAS. Prevalence of 8%. Male sex or age at onset >50 + MCV >100 + platelet count< 200 classified between VEXAS and RP with 100% sens and 96% spec @rheumnow @petercgrayson #ACR20 Abstr#509 #ACRbest https://t.co/5QMu4Y6xSH

Highlighting results from @rheum_covid at #ACR20 Race/ethnicity Associated with Poor Outcomes in #RheumaticDisease Patients with #COVID19 by @MilenaGianfran et al Abstract #0006👉https://t.co/13jsl8BjcH Full paper👉https://t.co/Qeo0dOoIOQ @RheumNow https://t.co/U9cgaYYaOj

• Race/ethnicity Is Associated with Poor Health Outcomes Amongst Rheumatic Diseas…
• Race/ethnicity Is Associated with Poor Health Outcomes Amongst Rheumatic Diseas…
• Race/ethnicity Associated with Poor Outcomes in Rheumatic Disease Patients with…

#ACR20 keynote Infectious disease Dr Eric Rubin @NEJM EIC answers questions about medications, immunity and vaccines in #COVID19. Many post covid inflammatory symptoms but not sure if its because of background autoimmunity. Need more data. More to come in a few months @RheumNow

#ACR20 Basic Science Year-in-review Really important work by @danaorange showing PRIME cells can predict flares in #RheumatoidArthritis patients #HSSrheum @RheumNow https://t.co/XTqqinAN2a https://t.co/24HkqgHS0H

• https://www.nejm.org/doi/10.1056/NEJMoa2004114

Proud of #HSSRheum! Check out the full list of our 76 Abstracts and 27 moderator and speaker sessions at #ACR20 Convergence here: https://t.co/OoQSzoRxGq. Special congratulations to our two awardees - Roberta Horton and Dr. Jane Salmon! https://t.co/cDkzgFtEH3

• HSS at the 2020 ACR Annual Scientific Meeting

Emerging trend #MachineLearning - SpA expert Dr Dennis Poddubnyy talks at #ACR20 press conference - Development and Validation of an #artificial_intelligence Approach for the Detection of Radiographic Sacroiliitis using MRI @RheumNow

#ACR20 year in review by @JYazdanyMD latest data PEXIVAS and SEMIRA trials on corticosteroids - would you change your clinical practice to minimize even low dose Corticosteroids in RA and Vasculitis? @RheumNow https://t.co/l7PTyANpjq https://t.co/MRGbsjaGae

• DEFINE_ME
• https://www.nejm.org/doi/full/10.1056/nejmoa1803537

Ready for #ACR20 with an obstructed view. @RheumNow https://t.co/oFVc90DpEM